Cold & Cough Remedies - Philippines

In the Philippines, the revenue in the Cold & Cough Remedies market market in 2024 reaches US$252.70m.
It is projected to experience an annual growth rate of 9.41% (CAGR 2024-2029).
Among all countries, the United States leads in terms of revenue generation, with US$11.19bn in 2024.
Looking at the per person perspective, in 2024, the revenue generated amounts to US$2.12 per individual.
The demand for cold and cough remedies in the Philippines is increasing due to the country's high prevalence of respiratory illnesses.

Definition:
The Cold and Cough market comprises over-the-counter natural and synthetic agents to relieve cough, expectorants and sore throat remedies, cold remedies and preparations against flu-like infections. Cough and cold medication includes medicines in the form of pills, syrups, lozenges, sprays, ointments and granulate for external and internal application. Not included are prescription medicines, preparations that are against the state law or are no explicit cold or cough drugs (e.g. painkillers). Among the top-selling medicines for cold and cough are nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, Isla Moos. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
In the form of pills, syrups, creams, lozenges, sprays and granulate
Expectorants and remedies to relieve cough

Prescription medicines
Homeopathic remedies
Painkillers
Candy

The Cold & Cough Remedies market in Philippines has been experiencing steady growth in recent years.

Customer preferences: Customers in the Philippines have shown a strong preference for over-the-counter cold and cough remedies. This can be attributed to several factors, including the convenience and accessibility of these products. Many consumers prefer to self-medicate for common cold and cough symptoms, rather than seeking a doctor's prescription. Additionally, the relatively low cost of over-the-counter remedies makes them an attractive option for price-conscious consumers.

Trends in the market: One of the key trends in the Cold & Cough Remedies market in Philippines is the increasing demand for natural and herbal remedies. Consumers are becoming more health-conscious and are seeking products that are perceived as being safer and more natural. As a result, there has been a growing number of herbal and natural cold and cough remedies available in the market. This trend is also driven by the increasing popularity of alternative medicine and traditional healing practices in the country.Another trend in the market is the rising demand for combination products. These are cold and cough remedies that contain multiple active ingredients to address different symptoms. Combination products are favored by consumers as they offer a convenient solution for multiple symptoms in a single product. This trend is also driven by the busy lifestyles of consumers who prefer to have a single product that can address their various cold and cough symptoms.

Local special circumstances: The Philippines has a tropical climate, which makes the country prone to certain diseases and illnesses, including colds and coughs. The high humidity and temperature create favorable conditions for the spread of respiratory infections. This has contributed to the high demand for cold and cough remedies in the country.Additionally, the Philippines has a large population, which further drives the demand for cold and cough remedies. The country's growing urbanization and increasing population density have led to a higher risk of respiratory infections and the need for effective remedies.

Underlying macroeconomic factors: The growing middle class in the Philippines has contributed to the growth of the Cold & Cough Remedies market. As more people enter the middle class, they have more disposable income to spend on healthcare products, including cold and cough remedies. This has created a larger consumer base for these products.Furthermore, the increasing urbanization and modernization in the country have also played a role in the market's growth. Urban areas tend to have higher pollution levels and a higher risk of respiratory infections, which drives the demand for cold and cough remedies.In conclusion, the Cold & Cough Remedies market in Philippines is experiencing growth due to customer preferences for over-the-counter remedies, the increasing demand for natural and herbal remedies, and the rising popularity of combination products. The local special circumstances of the country's tropical climate and large population also contribute to the market's growth. Additionally, underlying macroeconomic factors such as the growing middle class and urbanization further drive the demand for cold and cough remedies in the Philippines.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.